Title : Pharmacology of PCSK9 Inhibitors: Current Status and Future Perspectives.

Pub. Date : 2018

PMID : 30317986






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Ongoing research has led to the development of new PCSK9 inhibitors through genome editing technology (CRISPR-Cas9), siRNA or antisense oligonucleotide silencing agents, vaccines, mimetic peptides, adnectins, and inhibitors of PCSK9 secretion. Oligonucleotides proprotein convertase subtilisin/kexin type 9 Homo sapiens